clinical study of positron emission tomography with 3-deoxy-3-[18F]-fluoro-D-glucose

Not Applicable

• Conditions: healthy adult volunteer, cancer, epilepsy, Moyamoya disease,Alzheimer' s disease

• Registration Number: JPRN-UMIN000008871
• Lead Sponsor: Center for Integrated Human Brain Science, Brain Research Institute, University of Niigata

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-09-07
• Study Completion: 2019-02-28
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Not provided

Exclusion Criteria

exclude the patients who are recognized as inadequate patients by doctors with resposibility in this study

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
visualization of the lesion

Secondary Outcome Measures

Name	Time	Method
Confirmation of the differences between 3FDG-PET and conventional 2FDG-PET